Navigation Links
Aribex Unveils New Handheld Intraoral X-ray System - NOMAD Pro
Date:2/19/2008

OREM, Utah, Feb. 19 /PRNewswire/ -- Aribex, Inc., the worldwide leader in handheld X-ray technologies, today unveiled the NOMAD Pro, the most-advanced intraoral X-ray system available. The NOMAD Pro builds upon the heritage of Aribex's award-winning NOMAD X-ray system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080219/LATU057)

"The NOMAD has forever changed the way that dental radiography is performed by allowing an operator to safely stay in the room during a dental X-ray procedure," said Dr. D. Clark Turner, president and chief executive officer of Aribex, Inc. "The NOMAD Pro extends the NOMAD's battery-powered handheld platform by introducing a full color LCD display screen, preset exposure settings, and additional time saving features in a smaller and sleeker design."

With the NOMAD Pro, the operator stays right next to the patient, positions the NOMAD Pro and simply takes the radiograph. Not only does this save time for the operator, the time the patient has to hold still with film or a sensor in his/her mouth is shortened and patient comfort is increased.

The NOMAD Pro is designed for heavy general purpose use and is ideal for use with children, sedated patients, or special needs patients. The number of retakes needed when using the NOMAD Pro is dramatically reduced over conventional dental X-ray systems. The NOMAD Pro can easily be used in the office and then taken to the hospital, nursing home, or any location for treatment at the point-of-care.

The NOMAD Pro's battery gives hundreds of diagnostic-quality radiographs in just one charge. And weighing in at five and a half pounds, the NOMAD Pro can even be used by smaller operators.

The NOMAD Pro is safe to use. The NOMAD Pro incorporates modern internal shielding to block radiation leakage and a backscatter shield to protect the operator from X-rays scattered from the patient. This results in radiation exposure to the operator being more than one hundred times lower than regulatory limits.

Aribex and its NOMAD Pro dealers will begin taking orders for the NOMAD Pro for customers inside the United States at the 143rd Chicago Dental Society Midwinter Meeting (February 21 - 24, 2008 -- Aribex Booth #2747). Aribex anticipates the first customer deliveries of the NOMAD Pro to occur in 60 to 90 days. Aribex will continue to offer the state-of-the-art NOMAD through its established dealer channel.

About Aribex

Aribex, Inc. has quickly become recognized as the worldwide leader in innovative handheld x-ray products. Aribex is a privately owned, Orem, Utah-based company founded in 2003 with the mission to develop, manufacture, and market new technologies in the x-ray radiography fields. Aribex's flagship products are the NOMAD and NOMAD Pro handheld X-ray systems. The NOMAD's battery-powered handheld platform provides for expansion from dentistry into other x-ray imaging solutions such as veterinary, medical, industrial, and security applications. For more information, visit http://www.aribex.com.


'/>"/>
SOURCE Aribex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
2. iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning
3. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
4. United Concordia Unveils New Online Capabilities for Producers
5. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
6. Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre-Symptomatic Detection of Disease
7. Governor Rendell Offers Coverage to 29,000 on AdultBasic Waiting List; Unveils New Policy to Improve Quality of Care for the Low-Income and Pennsylvanians With Disabilities
8. Hy-Vee Unveils New Generic Drug Program
9. RSNA 2007: Siemens Medical Solutions Unveils an Unprecedented Number of Leading-Edge Solutions to Help Customers Improve Patient Care and Reduce Costs
10. SPO Medical Unveils New Oximetry Devices for European Markets
11. The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: